Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 25.28 | N/A |
| PEG Ratio (TTM) | 0.73 | N/A |
| P/S Ratio (TTM) | 3.65 | N/A |
| P/B Ratio (TTM) | 1.45 | N/A |
| P/FCF Ratio (TTM) | 13.21 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.02 | N/A |
| Price to 5YR AVG FCF Ratio | 11.34 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.86% | N/A |
| ROE (TTM) | 5.78% | N/A |
| Net Profit Margin (TTM) | 8.52% | N/A |
| ROIC 5YR AVG | 3.13% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 843.47% | -90.40% | 230.39% |
| Revenue | 10.85% | 7.15% | 4.88% |
| Net Income | 835.05% | -95.18% | 227.05% |
| Cash Flow | 26.66% | 12.89% | 8.03% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.59 | N/A |
| Quick Ratio (TTM) | 1.49 | N/A |
| D/E Ratio (TTM) | 3.35 | N/A |
| Interest Coverage (TTM) | 0.56 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.64 | N/A |
| LTL to 5YR AVG FCF | 18.96 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.41% | N/A |